Deciphera Pharmaceuticals Inc (NASDAQ:DCPH)

16.40
Delayed Data
As of Aug 12
 +0.64 / +4.06%
Today’s Change
6.51
Today|||52-Week Range
37.99
+67.86%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2018
Quarter 4
2018
Quarter 1
2019
Quarter 2
2019
Revenue and IncomeNet Revenues0.000.000.0025.0M
 
 
Depreciation And Amortization88.0K99.0K104.0K112.0K
 
 
 
 
 
 
Operating ExpensesGross Income-88.0K-99.0K-104.0K--
 
 
 
 
General Expenses25.8M33.7M48.9M47.9M
 
 
 
 
 
Research And Development20.6M27.4M35.8M34.8M
 
 
 
 
 
Total Operating Expenses25.9M33.8M49.0M48.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-25.9M-33.8M-49.0M-23.0M
 
 
 
 
 
Interest Expense On Debt21.0K20.0K13.0K25.0K
 
 
 
 
 
Other Expenses1.5M1.6M1.7M1.5M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-24.4M-32.3M-47.4M-21.5M
 
 
 
 
 
Net Income-24.4M-32.3M-47.4M-21.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS37.7M37.7M38.1M38.2M
 
 
 
 
 
Shares To Calculate EPS Diluted37.7M37.7M38.1M38.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.65-$0.86-$1.25-$0.56
 
 
 
 
 
EPS Diluted-$0.65-$0.86-$1.25-$0.56